Novo Nordisk (NYSE:NVO) Q3 2025 Earnings Call November 05, 2025 07:00 AM ET Company ParticipantsMike Doustdar - President and CEOHarry Sephton - Director of Pharma Equity ResearchRichard Foster - Client Care SpecialistMartin Lange - EVP of Research and Development and CSOKarsten Knudsen - CFOMichael Nedelcovych - Director of Equity ResearchDave Moore - EVP of US OperationsMartin Parkhøi - Head of Danish EquitiesJakob Rode - Head of Investor RelationsCarsten Madsen - Head of Equity ResearchLudovic Helfgott - ...